Press Releases
Search
-
17 Jan 2007
Cepheid and bioMérieux Enter Into Strategic Agreements
Marcy l'Etoile, France & Sunnyvale, USA (CA) - January 17, 2007. Cepheid (NASDAQ: CPHD) and bioMérieux (EuroNext: BIM) announced today that they have entered into a strategic relationship wherein both...
-
17 Jan 2007
2007-2012 Strategy
Marcy l'Etoile, France - January 17, 2007. bioMérieux, a global leader in the field of in vitro diagnostics, today announced its strategic plan for 2007-2012. In clinical applications, it is committed...
-
17 Jan 2007
2006 Sales Up 5.9% Like-For-Like
Marcy l'Etoile - January 17, 2007. bioMérieux, a global leader in the field of in vitro diagnostics, today announced its full-year 2006 sales. Net sales totaled €1,037 million versus €994 million in 2...
-
17 Jan 2007
bioMérieux licenses technology from NorChip to launch a HPV test for cervical cancer risk detection
Marcy l'Etoile, France - January 17, 2007. bioMérieux and NorChip announced today that bioMérieux has entered into a worldwide exclusive license agreement for rights developed by NorChip to an innovat...
-
19 Dec 2006
The Board of Directors of bioMérieux, chaired by Alain Mérieux, has appointed Stéphane Bancel Directeur Général délégué (Chief Executive Officer) of bioMérieux starting January 1, 2007
Marcy l'Etoile, France - December 19, 2006. bioMérieux announced today the appointment of Stéphane Bancel as Directeur Général délégué (Chief Executive Officer). His new position will become effective...
-
19 Dec 2006
bioMérieux to Phase Out Microplate Immunoassay Production in the United States
Marcy l'Etoile, France - December 19, 2006. bioMérieux, a global leader in the field of in vitro diagnostics, today announced it will phase out production of microplate immunoassay business at its Dur...